About: Lipid-altering efficacy of Ezetimibe/Simvastatin 10/20 mg compared to Rosuvastatin 10 mg in high-risk patients with and without type 2 diabetes mellitus inadequately controlled despite prior statin monotherapy     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
rdfs:seeAlso
Description
  • EZE/SIMVA was more effective than ROSUVA at lowering LDL-C, TC, non-HDL-C, and apoB in the overall study population and within both subgroups. Numerically, greater between-treatment reductions in LDL-C, TC, non-HDL-C, and apo B were seen in patients with T2DM versus those without T2DM. A significant interaction (P=0.015) was seen for LDL-C indicating that patients with T2DM achieved larger between-group reductions versus those without T2DM. Conclusions: Switching to EZE/SIMVA 10/20 mg versus ROSUVA 10 mg provided superior lipid reductions in patients with/without T2DM.
  • EZE/SIMVA was more effective than ROSUVA at lowering LDL-C, TC, non-HDL-C, and apoB in the overall study population and within both subgroups. Numerically, greater between-treatment reductions in LDL-C, TC, non-HDL-C, and apo B were seen in patients with T2DM versus those without T2DM. A significant interaction (P=0.015) was seen for LDL-C indicating that patients with T2DM achieved larger between-group reductions versus those without T2DM. Conclusions: Switching to EZE/SIMVA 10/20 mg versus ROSUVA 10 mg provided superior lipid reductions in patients with/without T2DM. (en)
Title
  • Lipid-altering efficacy of Ezetimibe/Simvastatin 10/20 mg compared to Rosuvastatin 10 mg in high-risk patients with and without type 2 diabetes mellitus inadequately controlled despite prior statin monotherapy
  • Lipid-altering efficacy of Ezetimibe/Simvastatin 10/20 mg compared to Rosuvastatin 10 mg in high-risk patients with and without type 2 diabetes mellitus inadequately controlled despite prior statin monotherapy (en)
skos:prefLabel
  • Lipid-altering efficacy of Ezetimibe/Simvastatin 10/20 mg compared to Rosuvastatin 10 mg in high-risk patients with and without type 2 diabetes mellitus inadequately controlled despite prior statin monotherapy
  • Lipid-altering efficacy of Ezetimibe/Simvastatin 10/20 mg compared to Rosuvastatin 10 mg in high-risk patients with and without type 2 diabetes mellitus inadequately controlled despite prior statin monotherapy (en)
skos:notation
  • RIV/61989592:15110/12:10213009!RIV13-MSM-15110___
http://linked.open...avai/riv/aktivita
http://linked.open...avai/riv/aktivity
  • N
http://linked.open...iv/cisloPeriodika
  • 2
http://linked.open...vai/riv/dodaniDat
http://linked.open...aciTvurceVysledku
http://linked.open.../riv/druhVysledku
http://linked.open...iv/duvernostUdaju
http://linked.open...titaPredkladatele
http://linked.open...dnocenehoVysledku
  • 147169
http://linked.open...ai/riv/idVysledku
  • RIV/61989592:15110/12:10213009
http://linked.open...riv/jazykVysledku
http://linked.open.../riv/klicovaSlova
  • type 2 diabetes; lipids; hypercholesteroelmia; coronary vascular disease (en)
http://linked.open.../riv/klicoveSlovo
http://linked.open...odStatuVydavatele
  • GB - Spojené království Velké Británie a Severního Irska
http://linked.open...ontrolniKodProRIV
  • [DB523C2BF8B6]
http://linked.open...i/riv/nazevZdroje
  • Cardiovascular Therapeutic
http://linked.open...in/vavai/riv/obor
http://linked.open...ichTvurcuVysledku
http://linked.open...cetTvurcuVysledku
http://linked.open...UplatneniVysledku
http://linked.open...v/svazekPeriodika
  • 30
http://linked.open...iv/tvurceVysledku
  • Averna, Maurizio
  • Missault, Luc
  • Vaverková, Helena
  • Viigimaa, Margus
  • Brudi, Philippe
  • Dong, Qian
  • Farnier, Michael
  • Johnson-Levonas, Amy
  • Shah, Arvind
http://linked.open...ain/vavai/riv/wos
  • 000301443500003
issn
  • 1755-5914
number of pages
http://bibframe.org/vocab/doi
  • 10.1111/j.1755-5922.2010.00181.x
http://localhost/t...ganizacniJednotka
  • 15110
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 91 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software